Search Results 1621-1630 of 21441 for anti-TNF drugs

1. Infliximab (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Overview - Translational Nanomedicine Program - Mayo Clinic Research

   ... treatment of cancer. Our research includes projects to develop a nanobiosensor and nanoplatforms for delivering drugs and monitoring outcomes. Our program's ...

3. Undifferentiated pleomorphic sarcoma - Symptoms and causes - Mayo Clinic

   Learn about this cancer that most often happens in the soft tissues of the arms and legs. Treatments include surgery, radiation therapy and chemotherapy.

4. Drug allergy - Doctors and departments - Mayo Clinic

   Learn which drugs are more likely to cause an allergic reaction, what symptoms look like and what treatments can calm such a reaction.

5. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Patients should be excluded if they have had prior treatment with anti-CTLA ...

6. Tamsulosin (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Flomax. Descriptions. Tamsulosin is used ...

7. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... therapy, unless PD was the best response to the line of therapy. Received as part of previous therapy a PI, an IMiD, and an anti-CD38 antibody (prior ...

8. Atovaquone (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Mepron. Descriptions. Atovaquone is used to prevent and ...

9. Advancement in CAR-T cell therapy for resistant B cell cancers - Mayo Clinic

   Mayo Clinic researchers have developed a CAR-T cell therapy targeting the B cell activating factor receptor (BAFF-R), prevalent in patients with B cell ...

10. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Patients who have previous treatment with an anti-PD-1, anti-PD-L1, anti-PD ...